Zeo ScientifiX ZEOX
OTC ZEOX
$1.18 -0.28 (-19.18%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zeo ScientifiX (ZEOX) Non Operating Interest Expenses (2017 - 2026)

Updated

Zeo ScientifiX (ZEOX) reported Non Operating Interest Expenses of $11,000 for fiscal Q2 2026 (quarter ended Apr 30, 2026), down 47.6% from $21,000 a year earlier but up 10.0% from the prior quarter.

Analysis

Zeo ScientifiX (ZEOX) Non Operating Interest Expenses (2017 - 2026) Analysis & Trends

Over the twelve months ended Apr 30, 2026, Zeo ScientifiX's Non Operating Interest Expenses came in at $76,000, down 13.6% year-over-year; for FY2025 (ended Oct 31, 2025), it was $98,000, up 6.5% from FY2024.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of -11.2% (FY2020 to FY2025).
  • By fiscal year, Non Operating Interest Expenses came in at $92,000 in FY2024 (-78.7%), $431,000 in FY2023 (+8.2%), $398,260 in FY2022 (+949.9%) and $37,934 in FY2021 (-78.7%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of $6,151 in fiscal Q4 2021 and a high of $172,000 in fiscal Q3 2023.
  • Year over year, Non Operating Interest Expenses gained in two of the last eight quarters, with an average decline of 29.1%.
  • The high point for year-over-year Non Operating Interest Expenses in five years was fiscal Q3 2022 (growth of 586.3%); the low point was fiscal Q3 2024 (a decline of 86.6%).
  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $10,000 (Q1 2026), $32,000 (Q4 2025) and $23,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Zeo ScientifiX 9.19 Mn 5.78 Mn 2.06 Mn 11,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 11,000.00
Jan 31, 2026 10,000.00
Oct 31, 2025 32,000.00
Jul 31, 2025 23,000.00
Apr 30, 2025 21,000.00
Jan 31, 2025 22,000.00
Oct 31, 2024 22,000.00
Jul 31, 2024 23,000.00
Apr 30, 2024 20,000.00
Jan 31, 2024 27,000.00
Oct 31, 2023 90,000.00
Jul 31, 2023 172,000.00
Apr 30, 2023 109,000.00
Jan 31, 2023 61,000.00
Oct 31, 2022 75,066.00
Jul 31, 2022 133,648.00
Apr 30, 2022 149,242.00
Jan 31, 2022 40,304.00
Oct 31, 2021 6,151.00
Jul 31, 2021 19,473.00
API Access

Zeo ScientifiX Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ZEOX&period=max&api_key=YOUR_API_KEY